News
Latest News
Contact Us
Intra-articular injection of umbilical cord–derived mesenchymal stem cells is safe and effective for moderate to severe knee osteoarthritis with synovitis: a double blinded and randomized controlled trial
11/02/2026
BMC Musculoskelet Disord, 29/12/2025 Introduction Knee osteoarthritis (KOA) is a chronic degenerative disorder with a high and rapidly increasing prevalence due to population aging, leading
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravenous UMC119-06 in Patients with Acute Ischemic Stroke
09/02/2026
Int J Med Sci, 01/01/2026 Introduction Stroke remains one of the leading causes of death and long-term disability worldwide, with an increasing disease burden over
FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia
29/01/2026
FDA News, 08/12/2025 The U.S. Food and Drug Administration today announced it has approved Omisirge (omidubicel-onlv), the first hematopoietic stem cell transplant (HSCT) therapy to
Modular mastery of inflammation: umbilical cord mesenchymal stem cells as a therapeutic frontier
26/01/2026
Frontiers in Immunology, 19/12/2025 Introduction Inflammation plays a central role in the pathogenesis of many acute and chronic diseases, ranging from autoimmune and degenerative disorders
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
22/01/2026
Medical Xpress, 06/12/2025 Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease symptoms and low rates of
Genioglossus Dysfunction in Obstructive Sleep Apnea Hypopnea Syndrome and the Therapeutic Potential of Human Umbilical Cord Mesenchymal Stem Cells
19/01/2026
The FASEB Journal, 02/12/2025 The genioglossus is a key therapeutic target in OSAHS. Human umbilical cord mesenchymal stem cells (hUCMSCs), with their regenerative properties and
Mesenchymal stem cells combined with IFN-γ treatment versus mesenchymal stem cells monotherapy: safety and efficacy over five years extension follow-up
30/12/2025
Stem Cell Research & Therapy, 17/11/25 Background Although the pathogenesis of rheumatoid arthritis (RA) is not yet fully understood, updated studies have suggested that various
Safety and efficacy of umbilical cord-derived stem cell therapy for the treatment of cerebral palsy patients: a systematic review
23/12/2025
Orphanet Journal of Rare Diseases, 17/10/2025 Background Cerebral palsy (CP) is the most common cause of functional impairment in young children. CP is a group
Mesenchymal stem cells and platelet-rich plasma in the treatment of premature ovarian insufficiency: a scoping review
16/12/2025
Contraception and Reproductive Medicine, 25/09/2025 Introduction Premature ovarian failure (POF) is the state of menopause before the age of 40, where a women’s ovaries stop
Three-dimensional cartilage tissue engineering using placenta-derived extra-embryonic mesenchymal stem cells: From isolation to differentiation
09/12/2025
Biomedicines, 18/09/2025 Introduction Mesenchymal stem cells (MSCs) offer promising prospects for novel treatment modalities in cellular therapies and artificial organ production, due to their remarkable
